These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 10415906

  • 1. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands.
    Lalies MD, Hibell A, Hudson AL, Nutt DJ.
    Ann N Y Acad Sci; 1999 Jun 21; 881():114-7. PubMed ID: 10415906
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 21; 240(1):251-8. PubMed ID: 3100771
    [Abstract] [Full Text] [Related]

  • 4. Phenylethanolamine is a specific substrate for type B monoamine oxidase.
    Edwards DJ.
    Life Sci; 1978 Sep 18; 23(11):1201-7. PubMed ID: 713694
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul 18; 18(4):793-802. PubMed ID: 7938567
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Substrate selectivity of type A and type B monoamine oxidase in rat brain.
    Kinemuchi H, Wakui Y, Kamijo K.
    J Neurochem; 1980 Jul 18; 35(1):109-15. PubMed ID: 6778959
    [No Abstract] [Full Text] [Related]

  • 10. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A, Todd KG, Baker GB.
    Ann N Y Acad Sci; 2003 Dec 18; 1009():309-22. PubMed ID: 15028605
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of monoamine oxidase by clorgyline and deprenyl in circumventricular structures of rat brain.
    Kinemuchi H, Wakui Y, Arai Y, Kamijo K.
    Biochem Pharmacol; 1980 Oct 15; 29(20):2871-4. PubMed ID: 6776962
    [No Abstract] [Full Text] [Related]

  • 16. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P, Artigas F.
    J Neurochem; 1993 Dec 15; 61(6):2191-8. PubMed ID: 7504085
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phenylethylamine--deamination by multiple types of monoamine oxidase.
    Dial EJ, Clarke DE.
    Biochem Pharmacol; 1978 Dec 15; 27(19):2374-5. PubMed ID: 728190
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M, Jain S, Baquer NZ.
    Biochem Pharmacol; 1990 Nov 15; 40(10):2215-8. PubMed ID: 2123104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.